NR5A2 and type 1 diabetes mellitus: Activation of LRH‐1/NR5A2 in T1D iDCs significantly decreased the secretion of several members of the CC‐chemokine subfamily (CCL2, CCL24 and CCL26), all of which play roles in various inflammatory diseases by recruiting leukocytes to sites of inflammation (Figure 1J,K).55